Research ArticleASTHMA

In vivo reprogramming of pathogenic lung TNFR2+ cDC2s by IFNβ inhibits HDM-induced asthma

See allHide authors and affiliations

Science Immunology  09 Jul 2021:
Vol. 6, Issue 61, eabi8472
DOI: 10.1126/sciimmunol.abi8472

Article Information

vol. 6 no. 61

PubMed: 
Published By: 
History: 
  • Received April 3, 2021
  • Accepted May 21, 2021
  • .

Author Information

  1. Samira Mansouri1,
  2. Himanshu Gogoi1,
  3. Mauricio Pipkin2,
  4. Tiago N. Machuca2,
  5. Amir M. Emtiazjoo1,
  6. Ashish K. Sharma3 and
  7. Lei Jin1,*
  1. 1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL 32610, USA.
  2. 2Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Florida, Gainesville, FL 32610, USA.
  3. 3Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Florida, Gainesville, FL 32610, USA.
  1. *Corresponding author. Email: lei.jin{at}medicine.ufl.edu

Altmetric

Article usage

Article usage: July 2021 to July 2021

AbstractFullPdf
Jul 20215852486233

Stay Connected to Science Immunology